Instituto D'Or de Pesquisa e Ensino - Sao Paulo
Instituto D'Or de Pesquisa e Ensino - Sao Paulo
Av. República do Líbano, 611 - Ibirapuera, São Paulo - SP, 04501-000
Select an option
I am a doctor
I am a sponsor
Open studies
Non-Hodgkin Lymphoma
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma - GLOBRYTE - Hoffmann-La RocheSee more
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
Leukemia
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) - CELESTIAL-RRCLL - BeiGeneSee more
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) - cAMeLot-2 - Janssen Research & Development, LLCSee more
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) - cAMeLot-1 - Janssen Research & Development, LLCSee more
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) - cAMeLot-1 - Janssen Research & Development, LLCSee more
Multiple myeloma
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) - MagnetisMM-32 - PfizerSee more
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma - TakedaSee more
Bladder Cancer
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer - ADVANCED-2 - Protara TherapeuticsSee more
Endometrial Cancer
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer - Fern-EC-01 - BioNTech SESee more
Breast Cancer
TIL-Driven De-escalated Chemotherapy in Stage I-II TNBC - DespaTIL - D'Or Institute for Research and EducationSee more
Lymphoma
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
Rare diseases
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
Prostate cancer
A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer - Darolutamide - D'Or Institute for Research and EducationSee more
Colorectal cancer
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation - CodeBreaK 301 - AmgenSee more
